Global Health Limited has informed the Exchange regarding Grant of 10000 Options.
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Global Health Limited (Medanta) announced on August 6, 2025, that its Nomination and Remuneration Committee approved the grant of 10,000 stock options to a single employee under the GHL Employees Stock Option Scheme (ESOS), part of the GHL LTIP 2024 Plan. The exercise price is set at Rs. 2 per share (the face value). The total plan capacity allows for up to 14 lakh shares under Part A (ESOS), 3.5 lakh shares under Part B (ESPS), and about 53.7 lakh shares for secondary acquisition. The options will vest over a maximum of 5 years from the grant date, with a 3-year exercise window from the date of last vesting. The scheme is fully compliant with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
This is a small, routine ESOP grant to a single employee and is not material to shareholders. It signals the company is using long-term equity incentives to retain key talent, but the dilution impact from 10,000 shares is negligible relative to the company's overall share base.